Cell-Line Engineering: A Check-up Before you Scale up

| May 31, 2018

article image
Bioproduction is a booming industry, with more therapeutics being produced in cell culture than ever before. With increased workflow flexibility, decreased variability, and high product yields, cell-line engineering is here to stay. But before you take your bioproduction to the next level, you'll need to know a bit more about your product, your cells, and their health. It's time for a cell-line engineering check-up!

Spotlight

Suzhou Pharma Services

Suzhou Pharma Services, a division of Amerigen Pharmaceuticals, is a contract development and manufacturing organization focused on oral solid dose forms. With US offices located in East Brunswick, NJ and the primary manufacturing site located in Suzhou, China, we are licensed by the Chinese sFDA and the US FDA. The management team in China and the USA is comprised of highly experienced, Western trained leaders, averaging 20+ years experience with multi-national branded and generic pharmaceutical companies.

OTHER ARTICLES

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Comparing HydroxyChloroquine Trials

Article | April 1, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

Top Pharmaceutical Firms Urge FDA to Adopt Blockchain for Drug Tracking

Article | February 25, 2020

Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following the successful completion of a DLT pilot project with the Food and Drug Administration (FDA), according to reports on February 24, 2020. Though nascent, blockchain technology, the building blocks of Bitcoin (BTC) and other cryptocurrencies are fast gaining ground across various ecosystems, due to its immutability, security, privacy, and other intricate properties. In the latest development, 25 leading manufacturers of pharmaceutical products, logistics partners and other market participants in the pharma supply chain, have published a report that highlights the importance of blockchain technology in drug traceability.

Read More

A pharma outsourcing mission

Article | August 18, 2021

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

Spotlight

Suzhou Pharma Services

Suzhou Pharma Services, a division of Amerigen Pharmaceuticals, is a contract development and manufacturing organization focused on oral solid dose forms. With US offices located in East Brunswick, NJ and the primary manufacturing site located in Suzhou, China, we are licensed by the Chinese sFDA and the US FDA. The management team in China and the USA is comprised of highly experienced, Western trained leaders, averaging 20+ years experience with multi-national branded and generic pharmaceutical companies.

Events